Live
When will the FDA approve Compass Pathways' COMP360 Psilocybin? — COMP360 Psilocybin for Treatment-Resistant Depression
Starts:Mar 24, 2026, 2:00 PMEnds:Jan 1, 2028, 4:59 AM
AZRGMIKSHLMTNVGPLYPMU
Total volume
$23.2K
Largest spread
—
Outcomes
5
Platforms
1
Markets
1
Markets
Every market on this event, moneyline first. Select one to compare it across platforms in the side panel.
| Outcome | Best | Volume | Azuro | Gemini | Kalshi | Limitless | Novig | Polymarket | Polymarket US |
|---|---|---|---|---|---|---|---|---|---|
Before 2028 Favorite | 92.0%Kalshi | $1.1K | — | — | — | — | — | — | |
Before October 2027 | 89.0%Kalshi | $2.4K | — | — | — | — | — | — | |
Before July 2027 | 84.0%Kalshi | $8.7K | — | — | — | — | — | — | |
Before Mar 1, 2027 | 65.0%Kalshi | $4.3K | — | — | — | — | — | — | |
Before Jan 1, 2027 | 22.0%Kalshi | $6.8K | — | — | — | — | — | — |
Before 2028Favorite
92.0%Best · Kalshi$1.1K
Before October 2027
89.0%Best · Kalshi$2.4K
Before July 2027
84.0%Best · Kalshi$8.7K
Before Mar 1, 2027
65.0%Best · Kalshi$4.3K
Before Jan 1, 2027
22.0%Best · Kalshi$6.8K
AI-generated summary, may be inaccurate.
A detailed summary of this event hasn't been generated yet. Once available, it will explain the context, key contenders, and what each outcome resolves to.
Discussion (0)
Log in to join the discussion.
No comments yet — start the discussion.